About
CeloNova Biosciences develops FDA-approved coronary stent medical devices that incorporate a proprietary Polyzene-F (PzF) thin-film coating technology to improve hemocompatibility and reduce thrombosis risk in cardiovascular treatments.
Explore CeloNova Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.